DERMATOLOGICAL PHARMACEUTICALS

Brand Owner (click to sort) Address Description
BARRIER BARRIER THERAPEUTICS, INC. 600 College Road East, Suite 3200 Princeton NJ 08540 Dermatological pharmaceuticals;Research, development, and consultation in the field of dermatology;
RAMBAZOLE BARRIER THERAPEUTICS, INC. 600 College Road East, Suite 3200 Princeton NJ 08540 Dermatological pharmaceuticals;
RAMBAZOLE STIEFEL LABORATORIES, INC. 251 Little Falls Drive Wilmington DE 19808 Dermatological pharmaceuticals;
ZIMYCAN BARRIER THERAPEUTICS, INC. 600 College Road East, Suite 3200 Princeton NJ 08540 Dermatological pharmaceuticals;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is directed to a prevention and treatment for dermatological disorders. One aspect of this invention involves a dermatological treatment comprising one or more polypeptides with an amino acid sequence including KPV (SEQ. ID. NO. 1), MEHFRWGKPV (SEQ. ID. NO. 2), HFRWGKPV (SEQ. ID. NO. 3), or SYSMEHFRWGKPV (SEQ. ID. NO. 4) for the treatment and prevention of dermatological disorders. The polypeptides are at a level to effectively treat the cutaneous inflammation and are carried by a carrier. The one or more polypeptides can also be a dimer formed from any of the amino acid sequence above.